Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurgalys is an independent investment bank and consulting firm dedicated to the life sciences and healthcare sectors. Headquartered in Paris, France, the firm provides specialized services including corporate finance, company valuation, equity research, and strategic business development. Aurgalys assists biotechnology, medical technology, and pharmaceutical companies in navigating financial markets, securing funding, and executing mergers and acquisitions. The firm is recognized as a Listing Sponsor on Euronext, supporting small and mid-cap companies in their public listing processes. By combining scientific expertise with financial acumen, Aurgalys helps bridge the gap between innovative healthcare research and investment capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurgalys.